Telehealth Economics for Private Medical Practices
Telehealth economics for a practice are governed by reimbursement, visit mix, and workflow, not patient demand alone. A virtual visit carries lower facility cost but unchanged provider time, so it is profitable near in-person parity and marginal when discounted. According to CMS and commercial policy, telehealth reimbursement has shifted considerably, making payer policy the first variable to verify.
Telehealth economics for a practice are governed by reimbursement, visit mix, and workflow, not patient demand alone. A virtual visit carries lower facility cost but unchanged provider time, so it is profitable near in-person parity and marginal when discounted. According to CMS and commercial policy, telehealth reimbursement has shifted considerably, making payer policy the first variable to verify.
Telehealth arrived in most practices as an emergency improvisation and has stayed as a permanent question mark. Owners know patients like it and that competitors offer it, but few have ever pinned down whether their own telehealth visits make money, lose money, or simply move revenue around. The honest answer depends almost entirely on variables that live in payer contracts and visit mix rather than in patient enthusiasm, and getting it right means treating telehealth as a service line with its own economics, not a free convenience bolted onto the existing schedule.
Reimbursement Is the Whole Ballgame
The single biggest driver of telehealth economics is how the visit is reimbursed. According to CMS and commercial payer policy, telehealth reimbursement has shifted considerably since the public health emergency, with some payers paying virtual visits at parity with in-person care and others at a reduced rate, and the rules continue to evolve. When telehealth is reimbursed near parity, the lower facility and rooming cost makes it genuinely attractive. When it is discounted, the margin narrows quickly, because the provider time the visit consumes is identical either way.
This is why the first step is never a patient survey; it is verifying current, payer-specific telehealth reimbursement across your actual mix. A practice weighted toward payers that discount virtual visits faces very different economics from one whose payers hold parity, which ties telehealth directly to payer mix and reimbursement rates. The contracts decide whether telehealth is a margin or a loss before a single virtual visit is booked.
The Real Cost and the Right Visit Mix
A telehealth visit changes the cost structure rather than eliminating it. It avoids exam-room turnover, reduces front-desk rooming, and uses fewer supplies, while adding a platform subscription, a scheduling and tech-support workflow, and provider time that is unchanged from an in-person encounter. The net cost is usually lower than an in-person visit, which is exactly why the economics improve at parity and erode at a discount. Reading those numbers requires a clear sense of your in-person cost baseline, which is why telehealth analysis sits on top of your practice overhead benchmarks.
Visit mix is the second economic lever. Follow-ups, medication management, behavioral health, chronic-disease check-ins, and non-exam triage translate cleanly to a virtual encounter, while hands-on examinations, procedures, and diagnostics do not. Matching the right visit types to telehealth raises both clinical value and margin, whereas forcing the wrong ones virtual frustrates everyone and adds little revenue. Because provider minutes are the binding constraint, the visit-mix decision connects telehealth to panel size and provider capacity: telehealth fills the schedule more efficiently, but it does not multiply how many patients a clinician can carry.
Deciding Whether to Build the Service Line
For a smaller practice, the question is whether the platform and workflow investment is justified by the reimbursement and eligible visit volume, not by general enthusiasm for virtual care. A subscription, the workflow changes, and clinician buy-in are real costs, so the case rests on the specific economics of your payer mix and your eligible visit types. The practices that model this honestly before buying avoid paying for a virtual service line that never reaches sustainable volume. Structuring that evaluation, payer mix, technology stack, workflow integration, and clinician buy-in, is exactly what the telehealth readiness assessment is built to do.
Telehealth done well also supports the broader practice economics, because the right virtual visits reduce no-shows for appropriate appointment types and fill schedule gaps that an in-person calendar could not, which connects it to patient lifetime value through better continuity and retention. Treated as a priced, deliberate service line rather than a free feature, telehealth becomes one more lever in the operator toolkit mapped on the healthcare lead generation hub.
Related: payer mix and reimbursement rates.
Related: panel size and provider capacity.
Related: patient acquisition cost benchmarks.
Related: lead generation for healthcare practices.
The practices that lost money on telehealth almost all made the same mistake: they treated it as a free feature rather than a service line with its own economics. They bought a platform, announced virtual visits, and never checked whether their payers actually reimbursed them at a rate that covered the provider time. A service line you have not priced is a liability wearing the costume of an opportunity.
Summary
Key takeaways
- Telehealth profitability hinges on reimbursement: it is attractive when paid near in-person parity and narrows when discounted, so payer policy is the first variable to verify
- A virtual visit avoids exam-room and rooming cost while adding platform and workflow cost, so net cost is usually lower but provider time is unchanged
- Follow-ups, medication management, behavioral health, and chronic-care check-ins are the strongest telehealth fits; hands-on visits are not
- Telehealth raises effective capacity by cutting no-shows and filling schedule gaps, but provider time remains the binding constraint
Try it live
Assess Your Telehealth Readiness
Part of the Healthcare cluster.
I tell owners to start with payer policy, not patient demand, because policy is the variable that decides whether telehealth is a margin or a loss. Demand for virtual visits is rarely the constraint. The constraint is whether the visit pays enough to justify the provider minute it consumes, and that answer lives in the contracts, not in the patient survey.
Try the Telehealth Readiness Assessment
Rate payer mix, technology stack, workflow integration, and clinician buy-in and see a realistic telehealth launch path. Embed it on your consulting or vendor site to capture practices weighing a virtual service line.
Adam
Founder, CalcStack
Adam built CalcStack to help businesses turn website visitors into qualified leads using interactive content. The platform now serves hundreds of tools across every major industry.
Follow on X